Skip to content

What Women Should Know About the Depo-Provera Settlement Deadline

Women pursuing Depo-Provera brain tumor lawsuits face a November 30 settlement registration deadline, but other legal options still remain for many. Those affected should know who may qualify, when payments could begin, and the legal risks facing women who don't register for the settlement.

Syringe and medication vial beside a calendar with November 30 circled in red and a prominently displayed deadline reminder, representing the Depo-Provera settlement registration deadline.
Published:

Women pursuing lawsuits over the birth control injection Depo-Provera have until November 30, 2026, to register for a major settlement program. But the deadline doesn't apply to everyone who has used the contraceptive, and missing it could have significant consequences for women with pending claims.

The lawsuits allege that Depo-Provera and certain generic versions increased the risk of meningiomas, tumors that develop in the membranes surrounding the brain and spinal cord. Notable research connecting the birth control shot to meningiomas was released within the last few years and was a driving force for the influx of dangerous pharmaceuticals cases against Pfizer.

In December 2025, the FDA approved an updated Depo-Provera warning label addressing the risk, adding to questions about what Pfizer knew and when patients should have been warned.

While the settlement could provide compensation to thousands of women, others will continue pursuing their lawsuits under separate court rules. Understanding the difference is especially important as the deadline approaches.

What Is the Depo-Provera Settlement Deadline?

The November 30 registration deadline is part of a settlement agreement reached in July between Pfizer and attorneys representing plaintiffs in federal multidistrict litigation (MDL 3140). As of early November, there were over 6,400 cases in the federal Depo Provera MDL.

According to Case Management Order No. 14, the settlement is expected to resolve a substantial portion of the pending cases. Attorneys previously estimated that approximately 80% of federal plaintiffs would qualify.

BrownGreer, an independent claims administration firm, is overseeing settlement eligibility and registration. However, November 30 is a registration deadline, not a guaranteed payment date or a deadline for every woman who may have a Depo-Provera brain meningioma claim.

The settlement's detailed eligibility requirements are contained in a confidential agreement, making it important for women to confirm their individual status with an attorney.

Pfizer hasn’t admitted wrongdoing or liability through the settlement.

Who Can Register for the Depo-Provera Settlement?

For certain women who haven't yet filed a lawsuit, eligibility for the settlement process depends partly on when they hired an attorney.

Under Case Management Order No. 18, certain women who haven't filed lawsuits can use a special administrative court process to participate in the settlement.

To qualify for that process, they must have signed an agreement with an attorney to pursue a covered Depo-Provera claim on or before June 11, 2026, and meet the settlement's other eligibility requirements.

This means a woman who contacts an attorney for the first time in November cannot assume she can join the existing settlement. But it also doesn't mean she has no legal options.

The ability to pursue a separate birth control brain tumor lawsuit depends on a woman’s circumstances, including applicable filing deadlines and the evidence supporting her claim.

Given there are specific requirements and a set process to register for the Depo-Provera settlement, it’s best to speak to your lawyer or consult with one about your case and what your options are.

Registration vs. Settlement Acceptance: What it Means

Registering is part of seeking compensation, but it shouldn't be confused with accepting a settlement offer or receiving payment.

The settlement administrator must determine eligibility, review claims, and carry out the compensation process for women who filed Depo-Provera lawsuits. Plaintiffs’ attorneys can explain when they must formally accept an offer, what agreements they may need to sign, and what happens if they disagree with the proposed compensation.

These details matter because settling a lawsuit generally involves giving up the right to pursue a trial later on.

Unlike a class action settlement, the settlement agreement doesn't automatically resolve every woman's lawsuit simply because her case is part of the federal litigation.

When Will Depo-Provera Settlement Payments Begin?

According to Case Management Order No. 12, payments from the Depo-Provera settlement are expected to begin between January and March 2027. However, this doesn't guarantee that every eligible woman will receive compensation during that period.

Individual payments may depend on eligibility reviews, supporting medical records, compensation rules, and outstanding reimbursement claims.

The publicly available court orders don't establish a universal payout amount. Be cautious about online estimates promising specific compensation figures.

What Happens If You Don’t Join the Depo-Provera Settlement?

Women who are eligible for the birth control shot settlement but choose not to participate, along with certain women who don't qualify, may continue pursuing their dangerous pharmaceuticals lawsuits.

But the court has set requirements for these cases, and in general, those allegedly harmed by Depo-Provera must provide:

·        Documentation showing when they used the shot or another covered product

·        Medical records documenting their meningioma diagnosis, treatment, and injuries

·        A detailed statement about their claim and supporting evidence

·        Expert medical opinions addressing the connection between the contraceptive and their tumor, including alternative possible causes

For many plaintiffs who are choosing not to register for the settlement, these materials must be submitted within 90 days after they enter the ongoing litigation process. The court also requires certain notices to medical providers and others holding relevant records, mandatory mediation, and an in-person court appearance.

Failure to meet the requirements can result in dismissal with prejudice, meaning the brain tumor claim can’t simply be filed again.

These rules don't prevent women from continuing their brain tumor lawsuits, but they make the process considerably more challenging than participating in the settlement.

Another important difference involves the legal arguments that remain unresolved.

Pfizer has argued that federal law prevents certain failure-to-warn claims from proceeding because the FDA regulates prescription drug warnings. This defense is known as federal preemption.

Earlier this year, Pfizer doubled down on their preemption defense, arguing that federal drug-labeling requirements should override certain claims brought under state law.

The court is also considering general causation – whether the scientific evidence is sufficient to establish that the products can cause the alleged injury, brain meningiomas.

These issues matter most to women who don't participate in the settlement.

The judge has indicated that rulings on preemption and general causation will apply to cases continuing through litigation, but won't affect who qualifies for the settlement.

Women who settle may resolve their claims without waiting for major legal decisions. In contrast, those continuing with their lawsuit face the possibility that those rulings could weaken or end their cases.

What Should Women Do Before the November 30 Registration Deadline?

Women with existing Depo-Provera lawsuits should contact their attorneys before the registration deadline to get answers to crucial questions:

  1. Am I eligible? Confirm that the settlement covers your claim and all requirements have been met.
  2. Has my registration been submitted? Request confirmation rather than assuming the process is complete.
  3. What compensation could I receive? Ask about how injuries are evaluated, attorney fees, expenses, and potential deductions.
  4. What rights would I give up? Understand the consequences of accepting compensation from the birth control shot meningioma settlement compared with continuing litigation.
  5. What happens if I don't participate? Ask about upcoming deadlines, expert evidence requirements, and the risks of pursuing the case.

Women who used Depo-Provera and subsequently developed a meningioma but haven't filed a lawsuit should seek legal advice immediately. While there is a November 30 settlement deadline, it shouldn't be confused with the statute of limitations, which affect whether you can file an individual lawsuit or if you’ve missed your window of opportunity.

At the end of the day, the Depo-Provera meningioma settlement may provide thousands of women a way to resolve claims without years of additional litigation. For others, the legal process is far from over.

Legal Examiner Staffer

Legal Examiner Staffer

Legal Examiner staff writers come from diverse journalism and communications backgrounds. They contribute news and insights to inform readers on legal issues, public safety, consumer protection, and other national topics.

All articles
Tags: Health

More in Health

See all

More from Legal Examiner Staffer

See all

Legal Marketing